TY - JOUR
T1 - Serial measures of cardiac troponin T levels by a highly sensitive assay and incident atrial fibrillation in a prospective cohort of ambulatory older adults
AU - Hussein, Ayman A.
AU - Bartz, Traci M.
AU - Gottdiener, John S.
AU - Sotoodehnia, Nona
AU - Heckbert, Susan R.
AU - Lloyd-Jones, Donald
AU - Kizer, Jorge R.
AU - Christenson, Robert
AU - Wazni, Oussama
AU - DeFilippi, Christopher
N1 - Funding Information:
This research was supported by Contracts HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, and N01HC85086, and Grants HL080295 and HL102214 from the National Heart, Lung, and Blood Institute (NHLBI), with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided by AG023629 from the National Institute on Aging (NIA). A full list of principal Cardiovascular Health Study (CHS) investigators and institutions can be found at CHS-NHLBI.org. Additional funding was provided by Roche Diagnostics. Roche Diagnostics provided funding and laboratory reagents for the highly sensitive cardiac troponin T assay. Dr. deFilippi receives honoraria, consulting, and grant support from Roche Diagnostics and Siemens Healthcare Diagnostics; and consulting and grant support from Critical Diagnostics and BG Medicine.
Publisher Copyright:
© 2015 Heart Rhythm Society. All rights reserved.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - Background Various mechanisms in cardiac remodeling related to atrial fibrillation (AF) lead to elevated circulating cardiac troponin levels, but little is known about such elevations upstream to AF onset. Objective The purpose of this study was to study the association between circulating troponin levels as assessed by a highly sensitive cardiac troponin T (hs-cTnT) assay and incident atrial fibrillation (AF). Methods In a large prospective cohort of ambulatory older adults [the Cardiovascular Health Study (CHS)], hs-cTnT levels were measured in sera that were collected at enrollment from 4262 participants without AF (2871 with follow-up measurements). Incident AF was identified by electrocardiograms during CHS visits, hospital discharge diagnoses, and Medicare files, including outpatient and physician claims diagnoses. Results Over median follow-up of 11.2 years (interquartile range 6.1-16.5), 1363 participants (32.0%) developed AF. Higher baseline levels of hs-cTnT were associated with incident AF in covariate-adjusted analyses accounting for demographics, traditional risk factors, and incident heart failure in time-dependent analyzes (hazard ratio for 3rd tertile vs undetectable 1.75, 95% confidence interval 1.48-2.08). This association was statistically significant in analyses that additionally adjusted for biomarkers of inflammation and hemodynamic strain (hazard ratio for 3rd tertile vs undetectable 1.38, 95% confidence interval 1.16-1.65). Significant associations were also found when hs-cTnT levels were treated as a continuous variable and when examining change from baseline of hs-cTnT levels and incident AF. Conclusion The findings show a significant association of circulating troponin levels in ambulatory older adults with incident AF beyond that of traditional risk factors, incident heart failure, and biomarkers of inflammation and hemodynamic strain.
AB - Background Various mechanisms in cardiac remodeling related to atrial fibrillation (AF) lead to elevated circulating cardiac troponin levels, but little is known about such elevations upstream to AF onset. Objective The purpose of this study was to study the association between circulating troponin levels as assessed by a highly sensitive cardiac troponin T (hs-cTnT) assay and incident atrial fibrillation (AF). Methods In a large prospective cohort of ambulatory older adults [the Cardiovascular Health Study (CHS)], hs-cTnT levels were measured in sera that were collected at enrollment from 4262 participants without AF (2871 with follow-up measurements). Incident AF was identified by electrocardiograms during CHS visits, hospital discharge diagnoses, and Medicare files, including outpatient and physician claims diagnoses. Results Over median follow-up of 11.2 years (interquartile range 6.1-16.5), 1363 participants (32.0%) developed AF. Higher baseline levels of hs-cTnT were associated with incident AF in covariate-adjusted analyses accounting for demographics, traditional risk factors, and incident heart failure in time-dependent analyzes (hazard ratio for 3rd tertile vs undetectable 1.75, 95% confidence interval 1.48-2.08). This association was statistically significant in analyses that additionally adjusted for biomarkers of inflammation and hemodynamic strain (hazard ratio for 3rd tertile vs undetectable 1.38, 95% confidence interval 1.16-1.65). Significant associations were also found when hs-cTnT levels were treated as a continuous variable and when examining change from baseline of hs-cTnT levels and incident AF. Conclusion The findings show a significant association of circulating troponin levels in ambulatory older adults with incident AF beyond that of traditional risk factors, incident heart failure, and biomarkers of inflammation and hemodynamic strain.
KW - Atrial fibrillation
KW - Biomarker
KW - Cardiac remodeling Aging
UR - http://www.scopus.com/inward/record.url?scp=84928605173&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928605173&partnerID=8YFLogxK
U2 - 10.1016/j.hrthm.2015.01.020
DO - 10.1016/j.hrthm.2015.01.020
M3 - Article
C2 - 25602173
AN - SCOPUS:84928605173
SN - 1547-5271
VL - 12
SP - 879
EP - 885
JO - Heart Rhythm
JF - Heart Rhythm
IS - 5
M1 - 6091
ER -